Abstract:The incidence of cardiac metastatic tumors is up to 40 times higher than that of primary tumors. [ 1 ] What is more, cardiac metastatic tumors are often asymptomatic that they are found only at autopsy and seldom be reported. [ 2 ] Mainly malignant melanoma and primary mediastinal tumors, but also lymphoma, lung carcinoma, breast, esophagus, and leukemia, are cause of cardiac metastases. [ 3 ] In case of cardiac metastatic tumors, the prognosis is poor and therapeutic options limited. [ 4 ] Generally, patients with symptomatic heart metastases die within a few weeks, with a median survival of 4 weeks. [ 5–7 ] Malignant tumors can metastasize to the heart through 3 pathways: direct infiltration; blood diffusion; lymphatic spread. Direct invasion of mediastinum and intrathoracic tumors often leads to pericardial metastasis; Blood dissemination usually causes myocardial metastasis; Lymphatic spread often causes pericardial metastasis. Endocardial metastasis is relatively rare, usually caused by blood invading tumor cells entering the ventricular cavity, and can also be secondary to myocardial metastasis. [ 8 ] Tumors spread can occur, in descending order, to the pericardium, myocardium, epicardium, endocardium and less frequently to the intracavitary regions with predominance to the right-side of the heart. [ 9 ] We report a case of right ventricular metastasis from esophageal squamous cell carcinoma with relatively good prognosis. Presently, there is a lack of standard treatment methods for cardiac metastatic tumors. According to literature reports, the therapy is mainly targeted at the treatment of metastasis tumor, such as undergoing cardiac metastatic tumor resection. Surgery can relieve obstruction and alleviate patient symptoms, as well as diagnosis the nature of cardiac tumors. The patient we reported got relief after the early surgery and chemotherapy. Unfortunately, the COVID-19 broke and the patient died on Dec 19th, 2022. This patient took about 6 months from the diagnosis of cardiac metastasis to death, which far exceeded the median survival period of 4 weeks reported in previous literature. Considering the rarity of cardiac metastases and the current lack of effective treatment measures, we will report on the patient diagnosis and treatment process and share our treatment measures in the hope of providing valuable insights for the treatment of cardiac metastases.

Lung squamous cell carcinoma with metastases in the left atrium and left ventricle responds to treatment with immunotherapy: A case report

First report of a successful surgical management of left atrial myxoma coexisting with pulmonary squamous cell carcinoma and thymic cyst

Diagnosis and treatment of right ventricular metastasis from esophageal squamous cell carcinoma: An unusual case report and a literature review

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

Case Report: Lung cancer with rare cardiac and other multiple metastases

Cardiac angiosarcoma with lung metastasis presented with multiple halo signs: One case report and literature review

Positive therapy outcome of lung squamous cell cancer: A case report

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab

When tissue is not the only issue: Poorly differentiated lung squamous-cell carcinoma with adrenal, costochondral, and cardiac metastases - case report

Single-molecule targeted therapy shrinks lung lesions and improves bone metastases: A case report

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy

Metastatic Small‐Cell Lung Carcinoma Infiltrating the Heart: A Rare Case Diagnosed Using Imaging Data

Case Report: Efficacy of Anlotinib and Sintilimab in Treating Lung Adenocarcinoma with RET Fusion and PD-L1 Expression

Case Report: Therapeutic Response to Chemo-Immunotherapy in an Advanced Large Cell Lung Carcinoma Patient With Low Values of Multiple Predictive Biomarkers

Endocavitary Right Ventricular Cardiac Metastasis of a Lung Adenocarcinoma Treated by Surgery: A Case Report About a Novel Multimodal Therapeutic Approach

Immunotherapy As a Treatment for Small Cell Lung Cancer: a Case Report and Brief Review

Case Report: Assessment of primary myxofibrosarcoma in the left atrium using multimodal ultrasonography

Near Complete Response to a Pembrolizumab-Based Therapeutic Strategy in an Abdominal Metastatic Head and Neck Squamous Cell Carcinoma Case.

Cardiac Metastasis from Myxoid Liposarcoma Managed Successfully with Chemotherapy and Radiotherapy: Case Report and Review of the Literature

Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma